Evidence-based medication adherence in hispanic patients with systolic heart failure in a disease management program

Kathy Hebert, Julieta Beltran, Leonardo Tamariz, Elyse Julian, Andre Dias, Pat Trahan, Lee Arcement

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The Hispanic population is the fastest growing minority in the United States, yet there is a paucity of data regarding patient follow-up in heart failure disease management programs (HFDMPs) and evidence-based medication adherence. The purpose of this study is to measure the compliance of evidence-based medication use, specifically measuring angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) and β-blockers (BBs) in the Hispanic population, and compare these data to the white and black population. The authors conducted a cross-sectional study of 561 patients enrolled in an HFDMP at Jackson Medical Hospital in Miami, Florida. At the first visit, 82% of Hispanic, 75% of white, and 79% of black patients were taking ACEIs/ARBs, but only 21% of Hispanic, 35% of white, and 32% of black patients were taking target doses. Hispanic patients are as compliant with ACEI/ARB and BB regimens as are the white and black populations in HFDMPs in a setting of similar socioeconomic features.

Original languageEnglish
Pages (from-to)175-180
Number of pages6
JournalCongestive Heart Failure
Volume16
Issue number4
DOIs
StatePublished - Jul 1 2010

Fingerprint

Systolic Heart Failure
Medication Adherence
Disease Management
Hispanic Americans
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Heart Diseases
Heart Failure
Population
Compliance
Cross-Sectional Studies
hydroquinone

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Emergency Medicine
  • Emergency

Cite this

Evidence-based medication adherence in hispanic patients with systolic heart failure in a disease management program. / Hebert, Kathy; Beltran, Julieta; Tamariz, Leonardo; Julian, Elyse; Dias, Andre; Trahan, Pat; Arcement, Lee.

In: Congestive Heart Failure, Vol. 16, No. 4, 01.07.2010, p. 175-180.

Research output: Contribution to journalArticle

Hebert, Kathy ; Beltran, Julieta ; Tamariz, Leonardo ; Julian, Elyse ; Dias, Andre ; Trahan, Pat ; Arcement, Lee. / Evidence-based medication adherence in hispanic patients with systolic heart failure in a disease management program. In: Congestive Heart Failure. 2010 ; Vol. 16, No. 4. pp. 175-180.
@article{ebdbf364e6d843eb9567c9a2f1f7f277,
title = "Evidence-based medication adherence in hispanic patients with systolic heart failure in a disease management program",
abstract = "The Hispanic population is the fastest growing minority in the United States, yet there is a paucity of data regarding patient follow-up in heart failure disease management programs (HFDMPs) and evidence-based medication adherence. The purpose of this study is to measure the compliance of evidence-based medication use, specifically measuring angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) and β-blockers (BBs) in the Hispanic population, and compare these data to the white and black population. The authors conducted a cross-sectional study of 561 patients enrolled in an HFDMP at Jackson Medical Hospital in Miami, Florida. At the first visit, 82{\%} of Hispanic, 75{\%} of white, and 79{\%} of black patients were taking ACEIs/ARBs, but only 21{\%} of Hispanic, 35{\%} of white, and 32{\%} of black patients were taking target doses. Hispanic patients are as compliant with ACEI/ARB and BB regimens as are the white and black populations in HFDMPs in a setting of similar socioeconomic features.",
author = "Kathy Hebert and Julieta Beltran and Leonardo Tamariz and Elyse Julian and Andre Dias and Pat Trahan and Lee Arcement",
year = "2010",
month = "7",
day = "1",
doi = "10.1111/j.1751-7133.2010.00150.x",
language = "English",
volume = "16",
pages = "175--180",
journal = "Congestive Heart Failure",
issn = "1527-5299",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Evidence-based medication adherence in hispanic patients with systolic heart failure in a disease management program

AU - Hebert, Kathy

AU - Beltran, Julieta

AU - Tamariz, Leonardo

AU - Julian, Elyse

AU - Dias, Andre

AU - Trahan, Pat

AU - Arcement, Lee

PY - 2010/7/1

Y1 - 2010/7/1

N2 - The Hispanic population is the fastest growing minority in the United States, yet there is a paucity of data regarding patient follow-up in heart failure disease management programs (HFDMPs) and evidence-based medication adherence. The purpose of this study is to measure the compliance of evidence-based medication use, specifically measuring angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) and β-blockers (BBs) in the Hispanic population, and compare these data to the white and black population. The authors conducted a cross-sectional study of 561 patients enrolled in an HFDMP at Jackson Medical Hospital in Miami, Florida. At the first visit, 82% of Hispanic, 75% of white, and 79% of black patients were taking ACEIs/ARBs, but only 21% of Hispanic, 35% of white, and 32% of black patients were taking target doses. Hispanic patients are as compliant with ACEI/ARB and BB regimens as are the white and black populations in HFDMPs in a setting of similar socioeconomic features.

AB - The Hispanic population is the fastest growing minority in the United States, yet there is a paucity of data regarding patient follow-up in heart failure disease management programs (HFDMPs) and evidence-based medication adherence. The purpose of this study is to measure the compliance of evidence-based medication use, specifically measuring angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) and β-blockers (BBs) in the Hispanic population, and compare these data to the white and black population. The authors conducted a cross-sectional study of 561 patients enrolled in an HFDMP at Jackson Medical Hospital in Miami, Florida. At the first visit, 82% of Hispanic, 75% of white, and 79% of black patients were taking ACEIs/ARBs, but only 21% of Hispanic, 35% of white, and 32% of black patients were taking target doses. Hispanic patients are as compliant with ACEI/ARB and BB regimens as are the white and black populations in HFDMPs in a setting of similar socioeconomic features.

UR - http://www.scopus.com/inward/record.url?scp=77955163572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955163572&partnerID=8YFLogxK

U2 - 10.1111/j.1751-7133.2010.00150.x

DO - 10.1111/j.1751-7133.2010.00150.x

M3 - Article

C2 - 20662871

AN - SCOPUS:77955163572

VL - 16

SP - 175

EP - 180

JO - Congestive Heart Failure

JF - Congestive Heart Failure

SN - 1527-5299

IS - 4

ER -